Migraine is recognized globally as the seventh most disabling condition across all diseases, accounting for approximately 2.9% of all years lived with disability (YLDs). It is also the top cause of ...

Brain health advocates share tips for detecting Alzheimer’s Disease early, including tests and early signs. Plus, prevention ...

Eli Lilly has received approval in Australia to market its Alzheimer's treatment Kisunla. The pharmaceutical company said Wednesday the Australian Therapeutic Goods Administration granted marketing ...

Cigna’s pharmacy benefits unit Evernorth said the deal will bring prices down for employers and their workers.

Big Pharma is using dark money to fund groups that sound like patient advocacy organizations but represent the industry.

The supply of GLP-1 drugs for weight loss and diabetes treatment is expected to tighten this week with a federal deadline to ...

Squeezed by insurers and middlemen, independent pharmacists find themselves on the front lines of a tariff storm.

Antimicrobial-resistant (AMR) “superbugs” contribute to more than 4.5 million deaths globally per year and threaten to make ...

Roche, along with Bristol Myers Squibb, Novo Nordisk, AbbVie, Eli Lilly and others, is making inroads into molecular glues to ...